{"id":"W3028840094","doi":"10.1200/jco.2020.38.15_suppl.5539","title":"Health-related quality of life (HRQoL) for olaparib versus enzalutamide or abiraterone in metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations: PROfound.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Olaparib; Medicine; Enzalutamide; Prostate cancer; Cohort; Internal medicine; Oncology; Population; Quality of life (healthcare); Randomized controlled trial; Cancer; Androgen receptor; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009095789,0.0003790353,0.0009735182,0.0002099936,0.000155345,0.0005158571,0.0003205912,0.0003539805,0.002857262],"category_scores_gemma":[0.0009470152,0.0001718504,0.001600262,0.0002546485,0.0002202652,0.000390291,0.000341805,0.0009716618,0.0001982744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003990552,"about_ca_system_score_gemma":0.0004810945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005647132,"about_ca_topic_score_gemma":0.001655692,"domain_scores_codex":[0.9996226,0.0001787176,0.00002833009,0.00006493993,0.0000502141,0.00005522071],"domain_scores_gemma":[0.999606,0.00009345926,0.0001275728,0.00001927944,0.00001569397,0.0001379234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8690645,0.005132189,0.02293575,0.0008973405,0.002814673,0.00006808047,0.0001068476,0.001857716,0.006060946,0.00013218,0.001483688,0.08944597],"study_design_scores_gemma":[0.3056384,0.450573,0.2261493,0.0002360299,0.006138835,0.0003698369,0.0001873617,0.002579136,0.003430867,0.0005443392,0.004084271,0.00006870312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936442,0.004046253,0.0001381618,0.0002092438,0.00005328839,0.000197967,0.0008669887,0.00001410089,0.0008297742],"genre_scores_gemma":[0.9975916,0.000767715,0.000246439,0.0001601826,0.00003672812,0.0001878265,0.0006194003,0.000002501526,0.0003876225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002857262,"threshold_uncertainty_score":0.009558499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3671448797495531,"score_gpt":0.5279855929166039,"score_spread":0.1608407131670508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}